Plain-English translation of NCT07109999 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This is a research study that builds and follows a group of people with Alzheimer's disease who have specific biological markers of the disease. Researchers will track how your disease progresses over time and learn what factors influence how quickly or slowly Alzheimer's develops, so they can eventually predict and prevent progression in future patients.
Doctors need better ways to predict which Alzheimer's patients will decline quickly and which will progress slowly. By studying a large group of patients with confirmed disease markers, researchers can identify warning signs early and develop personalized prevention strategies tailored to individual risk.
You likely qualify if…
You likely don't qualify if…
You would visit Xuanwu Hospital for assessments where researchers will evaluate your memory, thinking, and neurological health. The study involves biomarker testing (brain imaging or spinal fluid samples) and ongoing monitoring to track how your condition changes over time. This is an observational study, meaning researchers follow and record your health status rather than giving you a new medication to test.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China